Biotech & Pharma

Biotech and Pharma refer to the commercial sectors that develop, manufacture, and market products based in the biological and chemical sciences. Multinational pharmaceutical companies have invested heavily in biotech as a potential source of new products. While some biotech products and activities are socially and ethically controversial, the biotech industry often opposes public oversight and regulation. Given its impact on public debate and public policy, especially as it blurs the lines between private enterprise and public interest, biotech’s interests must be transparent.


Biopolitical Times

After the heritable human gene editing headlines of late 2018, and considering that the stakes include the future of human biology and the prospect of a new high-tech eugenics, it is no surprise that discussions have continued. What was not widely anticipated, however, was the emergence of a connection between old-school transhumanism, mutated into biohacking, and modern cryptocurrency, in the service of monetizing “the production of designer babies and human germline genetic engineering.”

Antonio Regalado’s story in MIT Technology...

Aggregated News

As many people purchased consumer DNA tests in 2018 as in all previous years combined, MIT Technology Review has found.

Surging public interest in ancestry and health—propelled by heavy TV and online marketing—was behind a record year for sales of...

Aggregated News

Sometimes a marketing pivot serves a truth-telling function. A new television ad for the consumer DNA database FamilyTreeDNA asks the...

Aggregated News

A scientist in New York is conducting experiments designed to modify DNA in human embryos as a step toward someday...

Biopolitical Times
Biopolitical Times
Two 23andMe at-home DNA testing kits

Aggregated News

Woman looking and pointing at phone

Aggregated News

Stem cell injection needle

Aggregated News

Mother with three children--kissing one on the cheek and holding one

Aggregated News

Biopolitical Times